Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals reported $2.54B in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 502.85M 5.09M
Agios Pharmaceuticals AGIO:US USD 791.66M 41.12M
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Amgen AMGN:US USD 44.7B 22.52B
Arrowhead Research ARWR:US USD 574.81M 189K
Avrobio Inc AVRO:US USD 77.25M 22.71M
BioMarin Pharmaceutical BMRN:US USD 2.84B 90.65M
Bluebird Bio BLUE:US USD 351.07M 151.58M
Incyte Corp INCY:US USD 3.97B 121.22M
Intercept Pharmaceuticals ICPT:US USD 490.46M 49.67M
Ionis Pharmaceuticals IONS:US USD 2.54B 339.92M
Mirati Therapeutics MRTX:US USD 939.35M 169.61M
Moderna Inc MRNA:US USD 12.12B 1.31B
Neurocrine Biosciences NBIX:US USD 1.43B 20.7M
Novartis NVS:US USD 32.11B 4.8B
PTC Therapeutics PTCT:US USD 613.39M 80.39M
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Regulus Therapeutics RGLS:US USD 34.56M 9.52M
Sangamo BioSciences SGMO:US USD 227.09M 73.24M
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Takeda 4502:JP JPY 2.4T 197.99B
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Vertex Pharmaceuticals VRTX:US USD 12.97B 269.1M
Xencor XNCR:US USD 629.98M 45.37M